Evaluation of effectiveness of treatment paradigm for newly diagnosed type 2 diabetes patients in Chin: A nationwide prospective cohort study-Reference-Cited by-同舟云学术

Evaluation of effectiveness of treatment paradigm for newly diagnosed type 2 diabetes patients in Chin: A nationwide prospective cohort study

Published:2019-07-02 Issue:1 Volume:11 Page:151-161
ISSN:2040-1116
Container-title:Journal of Diabetes Investigation
language:en
Short-container-title:J Diabetes Investig

Author:

Cai Xiaoling¹,Hu Dayi²,Pan Changyu³,Li Guangwei⁴,Lu Juming³,Ji Qiuhe⁵^ORCID,Su Benli⁶,Tian Haoming⁷,Qu Shen⁸,Weng Jianping⁹,Zhang Danyi¹⁰,Xu Jie¹⁰,Ji Linong¹

Affiliation:

1. Departments of Endocrinology and MetabolismPeking University People's Hospital BeijingChina

2. Cardiology Peking University People's Hospital BeijingChina

3. Department of Endocrinology and Metabolism Chinese People's Liberation Army General Hospital Beijing China

4. Department of Endocrinology and Metabolism Fuwai Hospital Beijing China

5. Department of Endocrinology and Metabolism The Fourth Military Medical University Xi Jing Hospital Xi An China

6. Department of Endocrinology and Metabolism The Second Affiliated Hospital Dalian Medical University Dalian China

7. Department of Endocrinology and Metabolism Sichuan University West China Hospital Chengdu China

8. Department of Endocrinology and Metabolism Shanghai Tenth People's Hospital Shanghai China

9. Department of Endocrinology and Metabolism The Third Affiliated Hospital Sun Yat‐Sen University Guangzhou China

10. VitalStrategic Research Institute Shanghai China

Publisher

Wiley

Subject

General Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jdi.13092

Reference27 articles.

1. Diabetes in Asia

2. Prevalence of Diabetes among Men and Women in China

3. Prevalence and Control of Diabetes in Chinese Adults

4. Prevalence and Ethnic Pattern of Diabetes and Prediabetes in China in 2013

5. 8. Pharmacologic Approaches to Glycemic Treatment

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The long-term cost-effectiveness of once-weekly semaglutide versus sitagliptin for the treatment of type 2 diabetes in China;Health Economics Review;2024-04-02

2. A Cost-effectiveness Analysis of iGlarLixi Versus IDegAsp and Appropriate Price Exploration of iGlarLixi for Type 2 Diabetes Mellitus Patients in China;Clinical Drug Investigation;2023-03-21

3. A Guideline-Based Decision Tree Achieves Better Glucose Control with Less Hypoglycemia at 3 Months in Chinese Diabetic Patients;Diabetes Therapy;2021-05-29

4. Patient-reported outcomes for diabetes and hypertension care in low- and middle-income countries: A scoping review;PLOS ONE;2021-01-15

5. Choice across 10 pharmacologic combination strategies for type 2 diabetes: a cost-effectiveness analysis;BMC Medicine;2020-12